• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Schering-Plough gets Zubrin approval for osteoarthritis in dogs

July 1, 2003

Schering-Plough Animal Health Corp. has received approval by the U.S. Food and Drug Administration (FDA) for Zubrin? (tepoxalin) rapidly-disintegrating tablets for the control of pain and inflammation associated with osteoarthritis in dogs.

Schering-Plough Animal Health Corp. has received approval by the U.S. Food and Drug Administration (FDA) for Zubrin (tepoxalin) rapidly-disintegrating tablets for the control of pain and inflammation associated with osteoarthritis in dogs.Zubrin is the first in a new class of canine nonsteroidal anti-inflammatory drugs (NSAIDs) that have a unique dual-pathway mechanism of action. Zubrin is the only approved canine NSAID that inhibits both the cyclooxygenase (COX-1 and COX-2) and lipoxygenase (5-LOX) pathways, the company says.Additionally, Zubrin is the only canine medication using Zydis technology, which results in the tablet disintegrating within seconds of being placed in the dogs mouth. This enhances compliance and helps ensure complete dosing by reducing medication rejection. With the approval of Zubrin, veterinarians and owners now have a therapy that is safe and effective in the treatment of pain and inflammation of canine osteoarthritis, and is easy to administer, says Hubert Trentesaux, vice president, companion animal business, Schering-Plough Animal Health. With Zubrin, an otherwise healthy dog can now live a more normal life, without suffering the discomfort of osteoarthritis.The product was proven effective in extensive field studies, the company says. It is administered once daily, either with food or within one to two hours after feeding. The recommended dosage is 10 mg/kg or 20 mg/kg once daily on the initial day of treatment, followed by a daily maintenance dose of 10 mg/kg. The product is available in 50, 100 and 200 mg rapidly disintegrating tablets.

For fastest response call (908) 629-3015 or visit the Web site at www.ZubrinUS.com.

Related Content:

Products
Zoetis unveils Alphatrak 3 glucose monitoring system for cats and dogs
Zoetis unveils Alphatrak 3 glucose monitoring system for cats and dogs
 Vetstoria releases its Fill Rate platform
Vetstoria releases its Fill Rate platform
Communicating the importance of genetic screening
Communicating the importance of genetic screening

Advertisement

Latest News

3 Must-reads for National Pet Dental Health Month

Veterinary Dentistry Specialists first to apply human fracture repair technology to companion animals

Long Island University debuts College of Veterinary Medicine Learning Center

Paving the way for a more diversified veterinary profession

View More Latest News
Advertisement